Association and Functional Analysis of Ferroptosis-related Genes with Prostate Hyperplasia

Abstract

Objective: This study aimed to investigate the association and biological functions of ferroptosis-related genes with prostatic hyperplasia. Methods: Gene information from ferroptosis and prostatic hyperplasia databases was used to screen for ferroptosis-related genes associated with prostate hyperplasia. Protein-protein interaction (PPI), Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and enrichment analysis were employed to evaluate the interaction between these genes and prostatic hyperplasia. Results: Through PPI, GO, KEGG, and enrichment analysis, several ferroptosis-related genes associated with prostatic hyperplasia were identified, including phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA), mitogen-activated protein kinase 3 (MAPK3), GABA type A receptor associated protein like 1 (GABARAPL1), HRas proto-oncogene (HRAS), tumor suppressor gene p53 (TP53), MAPK1, and autophagy related protein 7 (ATG7). These genes were found to be involved in various biological processes and signaling pathways related to ubiquitin protein ligase binding, protein phosphatase binding, pre-autophagosomal structure, autophagy, the PI3K-Akt signaling pathway and so on. Core genes such as PIK3CA, MAPK3, GABARAPL1, HRAS, TP53, MAPK1, ATG7, EGFR, Kirsten rat sarcoma viral oncogene homolog, and coiled-coil myosin-like BCL2-interacting protein were also found to be associated with transcription factors MYC, ESR2, PML, JUN, and TP53. Protein drug prediction suggested that FTI-277, Ginkgolide A, Tipifarnib, Desvenlafaxine, and Defactinib could potentially target the core genes. Conclusion: This study revealed the association and biological functions of ferroptosis-related genes with prostatic hyperplasia, providing new clues and directions for understanding the pathophysiology of prostatic hyperplasia and selecting therapeutic targets. These findings also contributed to a deeper understanding of the relationship between iron metabolism and prostatic hyperplasia, providing new ideas and methods for the diagnosis and treatment of iron metabolism-related diseases.